Bristol-myers Squibb Stock Forecast

Buy or Hold candidate since Jul 16, 2026 Gain 7.93%

The Bristol-Myers Squibb stock price gained 0.694% on the last trading day (Friday, 31st Jul 2026), rising from $64.86 to $65.31. During the last trading day the stock fluctuated 3.35% from a day low at $63.53 to a day high of $65.66. The price has risen in 7 of the last 10 days and is up by 7.52% over the past 2 weeks. Volume fell on the last day by -6 million shares and in total, 10 million shares were bought and sold for approximately $665.02 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to rise 8.99% during the next 3 months and, with a 90% probability hold a price between $61.65 and $71.18 at the end of this 3-month period.

BMY Signals & Forecast

Mostly positive signals in the chart today. The Bristol-Myers Squibb stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $63.29 and $58.66. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 20.94%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. The stock had a Golden Star Signal on Friday, November 21, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Bristol-Myers Squibb stock

On the downside, the stock finds support just below today's level from accumulated volume at $57.52 and $56.95. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Bristol-Myers Squibb finds support just below today's level at $57.52. If this is broken, then the next support from accumulated volume will be at $56.95 and $54.00.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.13 between high and low, or 3.35%. For the last week, the stock has had daily average volatility of 2.95%.

Our recommended stop-loss: $63.32 (-3.04%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 29 days ago.)

Trading Expectations (BMY) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Bristol-Myers Squibb Company to open at $64.83, and during the day (based on 14 day Average True Range), to move between $64.48 and $66.14, which gives a possible trading interval of +/-$1.67 (+/-2.59%) up or down from last closing price. If Bristol-Myers Squibb Company takes out the full calculated possible swing range there will be an estimated 2.59% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $57.52, some $7.79 (11.93%) from the current price of $65.31, our system finds the risk reward attractive.

Is Bristol-Myers Squibb Company stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Bristol-Myers Squibb stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 4.324 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $64.83 ( 0.731%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk